| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/14/2005 | US20050154025 6-[4-(fluoro- or trifluoromethyl)pyridyl-4-(p-fluorophenyl)-5-methylimidazol-2-yl] pyridones; cyclization of 1-phenyl-1-pyridyl-1,2-diaminopropanes with an acid, amidine, or nitrile compound; neuropeptide Y receptor antagonists; cardiovascular and central nervous system disorders, metabolic diseases |
| 07/14/2005 | US20050154023 1-(4-methoxynaphthalene-1-sulfonyl)-2,3-dihydro-1H-indole-3-carboxylic acid [2-(1-methyl-pyrrolidin-2-yl)-ethyl]amide; selective affinity for 5-HT6 receptor; psychosis, schizophrenia, depression, neurological disorders, cognitive enhancement, Parkinson's disease, ALS, Alzheimer's, Huntington's disease |
| 07/14/2005 | US20050154022 Selective antagonists for melanin concentrating hormone-1 (MCH1) receptors; antidepressants, anxiolytic agents; bipolar, eating, psychological, urogenital, and obsessive-compulsive disorders; phobias, post-traumatic stress disorder |
| 07/14/2005 | US20050154019 Substituted cyclic amine metalloprotease inhibitors |
| 07/14/2005 | US20050154008 Aryl fused substituted 4-oxy-pyridines |
| 07/14/2005 | US20050154005 Administering to a subject in need of such treatment an effective amount of 1,1'-[1,4-(phenylenebis(methylene))]bis-1,4,8,11-tetraazacyclotetradecane or a pharmaceutical composition thereof, wherein the inhibition of CXCR4 receptor binding effects treatment or amelioration of said condition |
| 07/14/2005 | US20050153998 Tetrahydroisoquinoline or isochroman compounds |
| 07/14/2005 | US20050153997 Fredericamycin derivatives |
| 07/14/2005 | US20050153987 Compounds |
| 07/14/2005 | US20050153986 Psychiatric and mood disorders, Bipolar Disorder, Circadian rhythm disorders, sleep disorders, pain, Parkinson's disease, cognitive dysfunction, epilepsy, obesity, drug addiction, drug abuse, drug withdrawal; side effects reduction; 1-Methyl-3-[3-(5-pyridin-2-yl-2H-tetrazol-2-yl)phenyl]imidazolidin-2-one |
| 07/14/2005 | US20050153984 4-[5-(4-trifluoromethyl-phenyl)-pyridin-3-yloxy]-benzothiazol-2-ylamine; inflammatory or neuropathic pain and diseases involving sensory nerve function such as asthma, rheumatoid arthritis, osteoarthritis, inflammatory bowel disorders, urinary incontinence, migraine and psoriasis |
| 07/14/2005 | US20050153980 Substituted indoles |
| 07/14/2005 | US20050153979 Novel piperidine-substituted indoles-or heteroderivatives thereof |
| 07/14/2005 | US20050153975 Y823D, N822K or D816H mutations in the c-Kit tyrosine kinase; antitumour agent; alternative to radiation or chemotherapy; reduce consequent infertility; good tolerability of compound mesylate treatment; no drug-related liver, renal or cardiac toxicity |
| 07/14/2005 | US20050153974 Heterocyclymethylpiperidines and -piperazines possessing affinity at 5ht-1 type receptors |
| 07/14/2005 | US20050153972 Triazole compounds |
| 07/14/2005 | US20050153966 2-hydroxy-1H-indol derivatives enzyme inhibitors for preventing or treating inflammation, inflammatory bowel disease, psoriasis, dementia related diseases Alzheimer's Disease, Cognitive Impairment, arthritis, neurodegenerative diseases, amyotrophic lateral sclerosis, Down syndrome, Huntington's Disease |
| 07/14/2005 | US20050153965 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| 07/14/2005 | US20050153964 Novel compounds |
| 07/14/2005 | US20050153960 Substituted arylamine derivatives and methods of use |
| 07/14/2005 | US20050153959 Heterocyclic anti-migraine agents |
| 07/14/2005 | US20050153958 Substituted aryl ketones |
| 07/14/2005 | US20050153942 Heterocyclic inhibitors of MEK and methods of use thereof |
| 07/14/2005 | US20050153900 Novel inhibitors of hepatitis C virus NS3/NS4a serine protease |
| 07/14/2005 | US20050153371 Conjugated small molecules |
| 07/14/2005 | US20050151467 Electrochromic salts, solutions, and devices |
| 07/14/2005 | DE10358004A1 Ketolactam-Verbindungen und ihre Verwendung -Keto lactam compounds and their use |
| 07/14/2005 | CA2801848A1 Methods for controlling sr protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control sr protein activity |
| 07/14/2005 | CA2551604A1 Amidopyrazole derivative |
| 07/14/2005 | CA2551602A1 Methods for controlling sr protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control sr protein activity |
| 07/14/2005 | CA2551227A1 Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
| 07/14/2005 | CA2550894A1 Plant growth regulation |
| 07/14/2005 | CA2550730A1 Method and compositions for identifying anti-hiv therapeutic compounds |
| 07/14/2005 | CA2550649A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |
| 07/14/2005 | CA2548309A1 Aryl sulfonamide compounds and uses related thereto |
| 07/13/2005 | EP1553097A1 Quinazoline derivatives as angiogenesis inhibitors and intermediates therefore |
| 07/13/2005 | EP1553096A1 Pyrazole compounds |
| 07/13/2005 | EP1553092A1 Aralkyl formyl-alkyl piperazine derivatives and their uses as cerebral nerve protective agent |
| 07/13/2005 | EP1553089A1 Antagonist of melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredient |
| 07/13/2005 | EP1553085A1 Cyclic amine derivatives and their use as drugs |
| 07/13/2005 | EP1553084A1 Piperidine derivative, process for producing the same, and use |
| 07/13/2005 | EP1551834A1 Substituted quinazolinone compounds |
| 07/13/2005 | EP1551830A2 Heterocyclically substituted indolinones and their use as receptor tyrosine kinase inhibators |
| 07/13/2005 | EP1551829A2 Novel compounds with antibacterial activity |
| 07/13/2005 | EP1551827A1 Piperidine derivatives as ccr5 inhibitors |
| 07/13/2005 | EP1551826A1 Hydantoine derivatives and their use as tace inhibitors |
| 07/13/2005 | EP1551825A1 Novel direct black dyes with three heteroaromatic rings |
| 07/13/2005 | EP1551824A1 Protein tyrosine kinase inhibitors |
| 07/13/2005 | EP1551823A1 4-amino-azepan-3-one compounds as cathepsin k inhibitors useful in the treatment of osteoporosis |
| 07/13/2005 | EP1551812A2 Mitotic kinesin inhibitors |
| 07/13/2005 | EP1551811A1 Benzimidazole derivatives and their use as vanilloid receptor ligands |
| 07/13/2005 | EP1551810A1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect |
| 07/13/2005 | EP1551809A1 Pyrazole compounds for treatment of neurodegenerative disorders |
| 07/13/2005 | EP1551804A1 Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/13/2005 | EP1551803A1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 07/13/2005 | EP1551795A1 Inhibitors of histone deacetylase |
| 07/13/2005 | EP1551408A1 4-(4-methylpiperazin-1-ylmethyl)-n- 4-pyridin-3-yl)pyrimidin -2-ylamino)phenyl -benzamide for treating anaplastic thyroid cancer |
| 07/13/2005 | EP1551404A2 Method of inhibiting angiogenesis |
| 07/13/2005 | EP1235802B1 Carbamate derivatives having muscarinic receptor antagonist activity |
| 07/13/2005 | EP1178969B1 Gastrin and cholecystokinin receptor ligands |
| 07/13/2005 | EP1161415B1 N-cyanomethylamides as protease inhibitors |
| 07/13/2005 | EP1042291B1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 07/13/2005 | EP0949249B1 Process for producing imidazole derivatives |
| 07/13/2005 | CN1639159A N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as DDP-IV inhibitors |
| 07/13/2005 | CN1639153A Indolylmaleimide derivatives |
| 07/13/2005 | CN1639152A Pyrrole-2, 5-dione derivatives and their use as GSK-3 inhibitors |
| 07/13/2005 | CN1639151A Novel azepane derivatives |
| 07/13/2005 | CN1639150A 异喹啉衍生物 Isoquinoline derivatives |
| 07/13/2005 | CN1639149A Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 07/13/2005 | CN1639148A 喹啉衍生物 Quinoline derivatives |
| 07/13/2005 | CN1639133A Novel antibacterial compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/13/2005 | CN1639132A N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 07/13/2005 | CN1639125A New inhibitors of histone deacetylase |
| 07/13/2005 | CN1639124A Aminotetralin derivatives as muscarinic receptor antagonists |
| 07/13/2005 | CN1639123A 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 07/13/2005 | CN1639121A 3-azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity |
| 07/13/2005 | CN1639120A Indolamid derivatives which possess glycogenphosphorylase inhibitory activity |
| 07/13/2005 | CN1639119A Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 07/13/2005 | CN1639096A Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative |
| 07/13/2005 | CN1638823A N-{5-[4-(4-methyl-piperazino-methyl)--benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents |
| 07/13/2005 | CN1638771A Form of presentation for 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester to be administered oral |
| 07/13/2005 | CN1638761A Azetidine derivatives as CCR-3 receptor antagonists |
| 07/13/2005 | CN1638757A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin |
| 07/13/2005 | CN1636996A Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands |
| 07/13/2005 | CN1636991A Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 07/13/2005 | CN1636990A Heterocyclic substituted aminoazacycles useful as central nervous system agents |
| 07/13/2005 | CN1636986A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636985A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636984A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636983A Substituted heterocyclic compounds |
| 07/13/2005 | CN1636981A Uracil compounds and their use |
| 07/13/2005 | CN1636977A 1, 3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 07/13/2005 | CN1636597A Compounds for the treatment of female sexual dysfunction |
| 07/13/2005 | CN1636564A Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 07/13/2005 | CN1210275C Respiratory syncytial virus replication inhibitors |
| 07/13/2005 | CN1210274C Piperazine and piperidine derivatives |
| 07/13/2005 | CN1210273C Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |
| 07/13/2005 | CN1210268C (Cyclo) alkyl substituted-gamma-aminobutyric acid derivatives (=GABA analogurs), their preparation and their use in the treatment of neurolog disorders |
| 07/13/2005 | CN1210265C Phthalazine derivatives and remedies for erectile dysfunction |
| 07/13/2005 | CN1210261C Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives having 5HT1A receptor activity |